Since early 2018, BaseLaunch has supported nine ventures that have, in total, raised over $180 million in financing. Several collaborations have been initiated and one company has been sold. As of early 2020, we have added another four companies to our portfolio and have also been instrumental in contributing to the development of six more ventures in the Basel Area.
During our first phase (2017-2019), BaseLaunch partnered with Roche, Novartis Venture Fund, J&J, Pfizer and Roivant Sciences. As a result of our success, in May 2020 we launched our second phase, increasing the funding available up to $500,000 per company. The partners for the Phase II have been announced recently and include Roche, BB Pureos Bioventures, Roivant Sciences, Bridge Bioventures, CSL Behring, Johnson & Johnson.
BaseLaunch is managed and operated by Basel Area Business & Innovation, the innovation and investment promotion agency for the Basel Area.